David Klein: Yes. That’s a really good question, Doug. And what I would say is that we’re — so we have a complete remediation plan, which is called out in the K, for the issues we experienced with BioSteel. We did do additional testing around the rest of our business to make sure that the BioSteel issues weren’t being replicated elsewhere, and that testing proved that it wasn’t happening elsewhere. Again, it was — this was a very involved process that included forensic accountants, outside legal experts, our own finance team, the dedication of our Audit Committee, which includes two former public company CFOs. So, we did a ton of work to make sure that we got completely to the bottom of the issues that required the restatement.
And as I said in the K, we call out our remediation plans and our Audit Committee has asked for check-ins on a biweekly basis with our progress toward those remediation plans, which we will, in fact, do. And I would say that then beyond that, several years ago, I think that the Canopy finance function was maybe in a difficult spot to take on the complexity of the business that we have. I would say that over the last few years, we’ve built what is generally a strong talented team that’s clearly committed to ensuring that we have a robust control environment. As a former public company CFO, I’m embarrassed that we had a — that we had to do a restatement. And we — as I said, we’ve taken the actions to remediate that, the items that caused that restatement.
And I do not expect us to have that kind of issue in any area of our control environment going forward.
Operator: There are no further questions at this time. So I will turn the conference back to Mr. Klein for any final remarks.
David Klein: Yes. Thank you, and thanks all for joining us today. So, to highlight the key takeaways from today’s call. We’ve made substantial progress in transforming our Canadian cannabis business during fiscal ‘23. And we’ve entered fiscal ‘24 focused on strengthening the business moving forward. We’ve completed the BioSteel Review and expect the fiscal ‘24 strategy to drive growth of the brand in North America while reducing our cash burn. And in fiscal ‘23, we introduced our Canopy USA strategy to optimize the value of our entire U.S. ecosystem. And we look forward to successfully concluding the regulatory review and progressing to a shareholder vote in the coming months. And finally, we continue to believe Canopy has significant opportunity ahead, both in Canada and the United States. Investor Relations will be available to answer additional questions. Have a good evening.
Operator: Ladies and gentlemen, this concludes Canopy Growth’s fourth quarter and fiscal 2023 financial results conference call. A replay of this conference call will be available until September 20, 2023, and can be accessed following the instructions provided in the Company’s press release issued earlier today. Thank you for attending today’s call, and enjoy the rest of your day. You may now disconnect your lines.
